. Development, Rockville, MD, USA The majority of these 11β-aryl substituted anti-progestins also bind the glucocorticoid receptor with high affinity and exhibit 4 To whom correspondence should be addressed anti-glucocorticoid activity (Neef et al., 1984; Gagne et al., Our goal was to determine the endocrine and post-coital , 1986 Busso et al., 1987) . In certain test systems, anti-fertility activity of CDB-2914. Concurrent administramifepristone and other anti-progestins have also exhibited tion of progesterone to rats on day 4 post-mating blocked progestational activity as well as weak anti-oestrogenic and the anti-fertility activity of a single oral 2 mg dose of anti-androgenic activity (Meyer et al., 1990 ; Hodgen et al., CDB-2914. CDB-2914 did not exhibit progestational activity 1994; Slayden and Brenner, 1994; Hackenberg et al., 1996) . in the oestradiol-primed immature female rabbit at doses Importantly, anti-progestins have shown considerable potential that exhibited anti-progestational activity. CDB-2914 antagin fertility control and in reproductive medicine such as in the onized exogenous and endogenous progesterone-stimulated treatment of breast cancer, endometriosis, and leiomyomata uterine haptoglobin synthesis and secretion in immature (Spitz and Bardin, 1993; Spitz et al., 1996; Cadepond et al. , and adult mated rabbits respectively. Neither CDB-2914 1997). Presently, the only clinically approved anti-progestin is nor mifepristone exhibited glucocorticoid activity as determifepristone which is administered acutely to induce medical mined by thymus involution in rats; mifepristone was twice abortions (Baulieu, 1991) . The acute administration of as potent as CDB-2914 in antagonizing glucocorticoid mifepristone circumvents undesirable anti-glucocorticoid action. Post-coital CDB-2914 treatment resulted in a doseeffects. For chronic or persistent disease states, a potent dependent reduction in implantation sites and pregnancy orally active compound with relatively pure anti-progestational rates in rabbits. CDB-2914-induced inhibition of uterine activity is needed. weight increase, endometrial glandular arborization and Currently, newer anti-progestins are being designed, syntheuterine haptoglobin synthesis/secretion correlated with sized, and tested in an attempt to identify a relatively pure inhibition of pregnancy in mated rabbits. A single oral progesterone antagonist. A promising 11β-aryl substituted, dose of 64 mg CDB-2914/rabbit was effective at blocking 17α-acetoxy progesterone analogue, CDB-2914, has been pregnancy when administered on day 4, 5, or 6 postshown to bind with high affinity to the progestin and glucomating, whereas 32 mg/rabbit was only partially effective corticoid receptor, and antagonizes progesterone action in the in this regard. These data demonstrate that CDB-2914 immature female rabbit with greater potency than mifepristone is a potent, orally active anti-progestin with weak antiwhen administered orally (Cook et al., 1992 (Cook et al., , 1994 . In addition, glucocorticoid activity. CDB-2914 inhibited implantation CDB-2914 demonstrated potent anti-ovulatory and post-coital in adult rats and rabbits demonstrating its potential as a anti-fertility activity in the rat indicating its potential use as a post-coital contraceptive drug.
post-coital contraceptive (Reel et al., 1998) . Anti-progestins Key words: agonist/antagonist/anti-fertility/glucocorticoid/progestin have also been shown to have contraceptive potential in female rhesus monkeys when administered at a low chronic dose (Zelinski-Wooten et al., 1998; Slayden et al., 1998) . The ovarian cycle was not affected in these monkeys; however, Introduction endometrial atrophy was apparent. Likewise, CDB-2914 was Several 11β-aryl substituted progesterone antagonists or antishown to suppress pregnancy in the rat when administered progestins have been synthesized and characterized in the past over a 24 day interval at a low daily dose (Reel et al., 1998) . decade. Mifepristone was the first steroid of this chemical Although CDB-2914 did not have detectable androgenic or class shown to bind the progestin receptor (PR) with high oestrogenic activity, CDB-2914 did demonstrate weak antiaffinity (Neef et al., 1984; Kloosterboer et al., 1988; androgenic and anti-oestrogenic activity in immature male and female rats respectively (unpublished data). The objective of the present study was to confirm and extend the biological Progestational/anti-progestational assays RU44675, and HRP 2000 in other publications; Cook et al., 1992 Cook et al., , 1994 Teutsch and Philibert, 1994; Tarantal et al., 1996;  Reversal of CDB-2914 post-coital anti-fertility activity with Wagner et al., 1996 Wagner et al., , 1999 
Materials and methods
were killed, the uteri excised, trimmed of extraneous tissue, blotted, and weighed (Elton and Edgren, 1958 Uteri were also collected from rabbits primed with 17β-oestradiol for in polycarbonate solid floor cages with Bed-o-Cob ® or Beta-Chip ® 6 days (n ϭ 3), and 17β-oestradiol rabbits treated subsequently with bedding (Andersons Industrial Products Group, Maumee, OH, USA) progesterone concurrently with either control vehicle or increasing and were fed Purina laboratory rodent diet (no. 5001) ad libitum. All doses of CDB-2914 orally for 5 days (n ϭ 5/group). After removing the animals received tap water ad libitum, except for adrenalectomized 2 cm utero-tubal segment for fixation, the cut ends of the uteri were male rats which received 0.9% saline ad libitum. The photoperiod clamped with haemostats and the uterine horns infused with 2-3 ml for the rabbit rooms was 12 h light/12 h dark and for the rat rooms per horn of Tris-buffered saline containing protease inhibitors (TBSwas 14 h light/10 h dark. The environmental conditions of the animal PI; Hoffman et al., 1996) and the cervical end of the uterine horns rooms were maintained as recommended in the Guide for the care clamped with another haemostat. Uteri were incubated 10-15 min, and use of laboratory animals (National Research Council, 1996) to the incubation fluid collected, centrifuged at 500 g for 10 min to the maximum extent possible. All study protocols were approved by remove cells and debris, and the supernatant fraction frozen and BIOQUAL's institutional animal care and use committee. stored at -70°C (Hoffman et al., 1996) . Protein concentration was determined in the uterine incubation Materials fluid using the Bradford method (Bradford, 1976) and samples For these studies, CDB-2914, 17α-acetoxy-11β-[4-N,N-dimethyl- diluted in electrophoresis sample buffer (Laemmli, 1970) lacking aminophenyl]-19 norpregna-4,9-diene-3,20-dione, was synthesized by β-mercaptoethanol and loaded (10 µg protein/lane) onto 12% acrylam-P.N.Rao, Southwest Foundation for Biomedical Research, San ide gels. Non-reducing sodium dodecyl sulphate polyacrylamide gel Antonio, TX, USA, under contract N01-HD-1-3137. The batch electrophoresis (SDS-PAGE) and subsequent transfer to nitrocellulose designated as CDB-2914P was used for all assays except for the membranes were completed as previously described (Hoffman et al., 1996) . A standard sample of uterine incubation fluid from a 6.75 day glucocorticoid/anti-glucocorticoid bioassays which used the batch pregnant rabbit was included on each gel as an internal control. designated CDB-2914R-2, and the reversal of post-coital anti-fertility
Estimates of relative uterine haptoglobin in the samples were obtained activity which used the batch designated as CDB-2914U. All batches by recording blot images on computer files (Adobe Photoshop, San were synthesized using the same procedure, were 99% pure based José, CA, USA) and scanning these files for relative density at the on high-performance liquid chromatography (HPLC) analyses, and location of the standard haptoglobin band (day 6.75 pregnant rabbit had similar potency in the immature rabbit anti-progestational bioassay uterine sample; PhospoImager ® , ImageQuant ® ; Molecular Dynamics (data not shown). Mifepristone was provided by Roussel-UCLAF, Inc., Sunnyvale, CA, USA). Under non-reducing conditions, the 42 Romainville, France and was 99% pure based on HPLC analysis.
kilodalton (kDa) β-haptoglobin is localized as part of a tetramer of Levonorgestrel was obtained from Schering AG (Berlin, Germany).
α and β subunits with a MW of~120 000 (Hoffman et al., 1996) . Other steroids were purchased from Steraloids Inc., (Wilton, NH, Volume densities were recorded and blots of individual treatment USA). Needles, syringes, anaesthetic, and surgical supplies were groups normalized to the density of the 120 kDa standard on each blot. purchased from A.J. Buck and Son Inc. (Owings Mills, MD, USA). Reagent grade chemicals were purchased from VWR Scientific Glucocorticoid/anti-glucocorticoid assays Products Inc. (West Chester, PA, USA) or Sigma Inc. (St Louis, MO, USA). Food grade sesame oil (Hain) was purchased from a local Young male rats (100-120 g) were adrenalectomized using aseptic surgical technique and treated s.c. with control vehicle, dexamethasone grocery store (Giant, Gaithersburg, MD, USA).
(glucocorticoid reference standard), or CDB-2914 or mifepristone for ism of endogenous progesterone, it was reasoned that it should 3 consecutive days (10/group). Twenty-four hours after the final dose, be possible to block the post-coital anti-fertility activity of rats were killed, the final body weight recorded, and the thymus CDB-2914 by the concurrent administration of progesterone.
gland excised, trimmed, blotted, and weighed (Ringler et al., 1964) .
Subcutaneous injection of 10 mg progesterone/rat at 0730 and For the anti-glucocorticoid bioassay, CDB-2914 or mifepristone were 1530 h along with 2 mg of CDB-2914 orally at 0930 h on given orally in an attempt to block s.c. administered dexamethasoneday 4 post-mating resulted in the maintenance of pregnancy or methylprednisolone-induced thymus involution.
in seven of 10 rats (Table I ). Confirming our earlier observation, the 2 mg dose of CDB-2914 alone abolished pregnancy in 10
Post-coital anti-fertility/anti-progestational activity in the mated rabbit of 10 rats. As expected, progesterone treatment alone had no adverse effects on pregnancy (Table I) (Cook et al., 1992 (Cook et al., , 1994 . CDB-2914 was three to determined. In other studies, female rabbits were treated orally with four times more potent by the s.c. than the oral route [ED 50 ϭ either the control vehicle (10% ethanol in sesame oil, n ϭ 7) or with 1.39 mg versus 5.19 mg (total doses), respectively]. CDBincreasing doses of CDB-2914 (n ϭ 6/group) on days 0-5 postmating (day 0 ϭ day of mating). Uteri were excised on day 6, the 2914 administered orally to oestradiol-primed immature female number of blastocysts was counted and flushed from the uterus with rabbits failed to stimulate endometrial glandular arborization TBS-PI. A 2 cm uterine segment from each horn was fixed for or to increase uterine weight (data not shown) at oral doses histological evaluation (McPhail, 1934) . Uterine incubation fluid that exerted anti-progestational activity, whereas the reference samples were obtained and the relative amount of haptoglobin progestogen, levonorgestrel, resulted in a dose-dependent determined as described above.
increase in both endpoints (data not shown). release in a dose-dependent manner (data not shown). Although no correlation (P Ͻ 0.05) was apparent between uterine weight Results and amount of haptoglobin in immature rabbits, a significant positive correlation (P Ͻ 0.01) existed between the production Progestational/anti-progestational assays of uterine haptoglobin and the degree of endometrial glandular Reversal of CDB-2914 post-coital anti-fertility activity with arborization. progesterone in the rat Recently, it was reported that a single oral dose of 2 mg CDBGlucocorticoid/anti-glucocorticoid assays 2914 was highly effective in blocking pregnancy in the rat when given orally on either day 4 or 5 post-mating (Reel Neither CDB-2914 nor mifepristone exhibited glucocorticoid activity in adrenalectomized male rats at total doses as high et al., 1998). Since this effect was presumably due to antagon- as 10 mg/rat (data not shown). In contrast, both compounds Post-coital anti-fertility/anti-progestational activity in the mated rabbit had detectable anti-glucocorticoid activity at a total dose of 9 mg/rat when dexamethasone (30 µg/rat total dose) was used as Oral administration of CDB-2914 on days 0-3 post-mating, the reference glucocorticoid (data not shown). However, neither during the peri-ovulatory and tubal egg transport period, compound was able to block completely dexamethasoneresulted in a dose-dependent reduction in implantation sites induced thymus involution. Therefore, an additional antiand pregnancy rates (Table II) . Pregnancy was blocked comglucocorticoid assay was performed using the less potent pletely at an oral dose of 16 mg/rabbit/day over the 4 day reference glucocorticoid, methylprednisolone (Kupfer and treatment period. Partridge, 1970) . Both CDB-2914 and mifepristone exhibited
Statistical analysis

Induction and antagonism of uterine haptoglobin synthesis
In addition, CDB-2914 given orally on days 0-5 posta dose-dependent inhibition of methylprednisolone-induced mating exhibited anti-progestational and post-coital antithymus involution (Figure 1) . At a total dose of 12 mg/ fertility activity in adult female rabbits (Table III) . Doserat, mifepristone and CDB-2914 partially prevented methyldependent inhibition of uterine weight and glandular arborizaprednisolone-induced thymus involution, however, mifeprition was observed in CDB-2914-treated mated rabbits and was stone was approximately twice as potent as CDB-2914 in accompanied by a decrease in pregnancy rate. At a daily dose this regard.
of 8 mg/rabbit, CDB-2914 resulted in a significant reduction (P Ͻ 0.05) in the number of uterine blastocysts and at 16 mg/ rabbit/day completely blocked pregnancy. Relative amount of uterine haptoglobin synthesis and secretion in mated adult female rabbits (data from same rabbits as Bars and brackets represent mean Ϯ SE, n ϭ 10/group. Bars with different letters were significantly different from each other based in Table III ). Bars and brackets represent mean Ϯ SE. Bars with different letters were significantly different (P Ͻ 0.05) from each on a one-way analysis of variance (ANOVA) followed by a Student-Newman-Keuls multiple range test to determine all other based on a Kruskal-Wallis ANOVA on ranks followed by Dunn's multiple range test. pairwise differences. CDB-2914 administered on days 0-5 post-mating also of endometrial glandular development in the uteri of rhesus monkeys (Koering et al., 1986; Ghosh et al., 1996) and women depressed the synthesis and secretion of uterine haptoglobin, (Gravanis et al, 1985; Greene et al, 1992 ; Gemzell-Danielsson a progesterone-induced protein implicated in the implantation et al., 1996, 1997) . In a recent phase I clinical trial, CDBprocess (Figure 2 ; Hoffman et al., 1996; Olson et al., 1997) .
2914 was reported to inhibit endometrial development in Mated adult rabbits treated with vehicle alone had increased women in a dose-dependent manner (Passaro et al., 1997) . uterine haptoglobin present in the uterine incubation fluid Although mifepristone demonstrated pure antagonist activity (Figure 2) which coincided with the presence of blastocysts in the rabbit bioassay, progestational activity has been detected in the uteri (Table III) . Significant positive correlations were in the endometrium of rhesus monkeys or women treated with observed among amount of uterine haptoglobin and uterine mifepristone in the absence of progesterone (Gravanis et al, weight (P Ͻ 0.01), degree of endometrial glandular arborization 1985; Koering et al., 1986; Wolf et al., 1989; Hodgen et al., (P Ͻ 0.01) , and the number of blastocysts present in the uterus 1994). Hence, the hormonal milieu appears to be important in (P Ͻ 0.01).
determining progestational agonist/antagonist activity. In an In another study, a single oral dose of 16 mg CDB-2914/ in-vitro transcriptional assay system, both mifepristone and rabbit was ineffective at blocking pregnancy when adminis-CDB-2914 demonstrated pure antagonist activity, whereas tered on either day 0, 1, 2, or 3 post-mating (data not shown).
other 11β-aryl analogues were classified as mixed agonists/ Hence, in a subsequent assay, higher single oral doses of 32
antagonists (Wagner et al., 1996) . These results for CDB-2914 and 64 mg CDB-2914/rabbit were administered orally on day were recently confirmed in the T47D cell alkaline phosphatase 4, 5, or 6 post-mating (6/group). The two higher doses were assay (Wagner et al., 1999) . Collectively, these data demongiven nearer the time of implantation in the rabbit based on the strated that CDB-2914 acted as a pure progesterone antagonist observation that CDB-2914 exhibited maximal effectiveness in in in-vivo and in-vitro systems. inhibiting pregnancy in the rat on days 4 and 5 post-mating
In conjunction with these effects on the endometrium, anti- (Reel et al., 1998) . A single oral dose of 32 mg CDB-2914/ progestins inhibit pregnancy. CDB-2914 has been shown to rabbit tended to reduce the pregnancy rate when administered prevent pregnancy in rats when administered at a low daily on days 5 and 6 post-mating, but did not inhibit pregnancy dose or as a post-coital contraceptive (Reel et al., 1998) . when given on day 4 post-mating (Table IV) . In addition, This post-coital anti-fertility activity is due to progesterone rabbits that were found pregnant following dosing on day 5 antagonism and is reversible as shown in the present study. or 6 post-mating tended to have a reduced number of normal CDB-2914 was also more potent than mifepristone in concepti and a slight increase in resorbing implantation sites.
terminating early pregnancy in the rat following oral A single oral dose of 64 mg CDB-2914/rabbit on day 4, 5, or administration (Teutsch and Philibert, 1994) , but was only 6 post-mating blocked pregnancy in all rabbits (Table IV) .
equally effective as an abortifacient in monkeys (Tarantal et al., 1996) . In the present study, CDB-2914 was able to Discussion completely block pregnancy in rabbits when administered In the present study, CDB-2914 acted as a pure anti-progestin orally after mating at doses as low as 16 mg/rabbit/day with no agonist activity in the immature rabbit bioassay.
for 5 days or at a single high dose (64 mg/rabbit). These Anti-progestational activity was presumably mediated through anti-fertility effects of CDB-2914 are probably mediated competitive binding to PR since CDB-2914 demonstrated a through multiple mechanisms involving progesterone action. relatively high binding affinity to PR (Cook et al., 1992 (Cook et al., , 1994  Mifepristone exhibited contragestational activity when adminunpublished data) and high doses of progesterone were able istered orally to rabbits at a daily dose of 5 mg/kg (17.5-20 to inhibit the post-coital anti-fertility activity of CDB-2914 in mg/rabbit) during days 8, 9 and 10 post-mating (Chang et al., the rat. Mifepristone has also been classified as a pure 1993). Mifepristone partially blocked ovulation in the rabbit antagonist with no agonist properties based on data in the at a single s.c. dose of 150 mg (17% ovulation rate, Kanayama et al., 1996) or at daily s.c. doses of 10 mg/kg for 3 days immature rabbit bioassay (Rauch et al., 1985) and inhibition Table III (52% ovulation rate, Chen et al., 1995) . CDB-2914 was also (Gagne et al., 1985 (Gagne et al., , 1986 Busso et al., 1987; Cook et al., 1992 Cook et al., , 1994 Wagner et al., 1999) . Mifepristone was a more capable of completely blocking ovulation in the rat when administered at a single oral dose of 2 mg during pro-oestrus potent anti-glucocorticoid than CDB-2914 in the rat thymolytic bioassay supporting qualitatively the in-vitro findings in a (Reel et al., 1998) . Mifepristone has also been shown to inhibit endometrial secretory production of uteroglobin in the rabbit glucocorticoid reporter gene assay in which mifepristone was found to be 100-fold more potent than CDB-2914 at inhibiting at doses of 10 mg/day for 6 days (Rauch et al., 1985) . In the present study, the anti-fertility effect of CDB-2914 in rabbits dexamethasone-stimulated transcriptional activity (Wagner et al., 1999) . However, the discrepancy between the relative was accompanied by a decrease in uterine haptoglobin. Uterine haptoglobin is a progesterone-dependent protein produced by potency of mifepristone compared to CDB-2914 in the in-vivo thymolytic bioassay (two-fold) versus the in-vitro transcripthe luminal epithelial cells during early pregnancy in the rabbit (Hoffman et al., 1996; Olson et al., 1997) . Amounts peak tional assay (100-fold) indicates that the in-vitro system does not quantitatively reflect the in-vivo situation. In vivo, the during the time of blastocyst attachment and implantation (days 6-7 post-mating). Since this protein is implicated in the N-mono-and didemethylated and hydroxylated metabolites of mifepristone may contribute as much as 47-69% of the antiimplantation process, CDB-2914 inhibition of haptoglobin production, or other secretory products, may be one of the glucocorticoid activity based on their RBA to GR (Heikinheimo et al., 1987) . Although the putative N-mono-and didemethylmechanisms by which CDB 2914 blocks pregnancy. Both mifepristone and CDB-2914 have been shown to retard endoated and hydroxylated metabolites of CDB-2914 demonstrated binding to GR (unpublished data), the binding affinities metrial development in women (Gemzell-Danielsson et al., 1994; Passaro et al., 1997) . The effects of mifepristone on the were lower than dexamethasone, whereas the mifepristone metabolites demonstrated greater binding affinity to GR than primate endometrium included inhibition of both glandular secretory development and stromal growth and oedema dexamethasone (Heikinheimo et al., 1987) . This finding suggests that the putative CDB-2914 metabolites contribute (Gemzell-Danielsson et al., 1994; Greb et al., 1999) . Administration of single 10 mg dose of mifepristone to less anti-glucocorticoid activity in vivo than do mifepristone's metabolites. women 5 days following unprotected intercourse reduced pregnancy rates (1.2%) indicating the effectiveness of antiAlthough mifepristone and CDB-2914 were equipotent when delivered directly to the uterine lumen, CDB-2914 was more progestins as emergency contraceptives (Piaggio et al., 1999) . Collectively, these data support the development of antipotent than mifepristone when administered orally (Cook et al., 1994) . This finding does not correspond directly to the progestins for contraceptive purposes and demonstrate their ability to block pregnancy through multiple mechanisms.
ability of mifepristone and CDB-2914 to bind PR in vitro and may reflect differences in the bioavailability of the Like mifepristone, CDB-2914 demonstrated in-vitro binding to the glucocorticoid receptor (GR), however, the receptor drug or the relative potency of the proximal metabolites following oral administration. The putative N-monodemethylbinding affinity (RBA) for CDB-2914 to GR tended to be lower than mifepristone (Wagner et al., 1999; unpublished ated metabolite of CDB-2914 demonstrated oral anti-progestational and anti-fertility activity in immature female rabbits and data). Both CDB-2914 and mifepristone demonstrated antiglucocorticoid activity with no agonist activity in the rat mated female rats respectively (unpublished data) indicating that this proposed metabolite may contribute to the overall thymolytic bioassay. These data support previously published studies indicating that CDB-2914 and mifepristone bind the anti-progestational activity of CDB-2914. The pharmacokinetic profile of CDB-2914 in rhesus monkeys indicated that CDB-GR with high affinity and act as glucocorticoid antagonists
